Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study

You'll need to have your competent? doctor analyze this and tell you what  needs to be done to prevent another stroke and dementia. You do expect your doctor to know about this before you bring it up? Don't you? Or are you giving them another pass like the non-knowledge they imparted about your stroke recovery?
Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study

1. Galit Weinstein, PhD,
2. Alexa S. Beiser, PhD,
3. Charles DeCarli, MD,
4. Rhoda Au, PhD,
5. Philip A. Wolf, MD and
6. Sudha Seshadri, MD, DM

+ Author Affiliations

1. From the Department of Neurology, Boston University School of Medicine, Boston, MA (G.W., A.S.B., R.A., P.A.W., S.S.); The Framingham Heart Study, Boston, MA (G.W., A.S.B., R.A., P.A.W., S.S.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (A.S.B.); and the Department of Neurology, University of California at Davis, Sacramento, CA (C.D.).

1. Correspondence to Sudha Seshadri, MD, DM, Department of Neurology, Boston University School of Medicine, B602, 72 East Concord St, Boston, MA 02118. E-mail suseshad@bu.edu

Abstract

Background and Purpose—Exposure to vascular risk factors has a gradual deleterious effect on brain MRI and cognitive measures. We explored whether a pattern of these measures exists that predicts stroke and Alzheimer disease (AD) risk.

Methods—A cognitive battery was administered to 1679 dementia and stroke-free Framingham offspring (age, >55 years; mean, 65.7±7.0) between 1999 and 2004; participants were also free of other neurological conditions that could affect cognition and >90% also had brain MRI examination. We related cognitive and MRI measures to risks of incident stroke and AD ≤10 years of follow-up. As a secondary analysis, we explored these associations in The Framingham Heart Study original cohort (mean age, 67.5±7.3 and 84.8±3.3 years at the cognitive assessment and MRI examination, respectively).

Results—A total of 55 Offspring participants sustained strokes and 31 developed AD. Offspring who scored <1.5 SD below predicted mean scores, for age and education, on an executive function test, had a higher risk of future stroke (hazard ratio [HR], 2.27; 95% confidence interval [CI], 1.06–4.85) and AD (HR, 3.60; 95% CI, 1.52–8.52); additional cognitive tests also predicted AD. Participants with low (<20 percentile) total brain volume and high (>20 percentile) white matter hyperintensity volume had a higher risk of stroke (HR, 1.97; 95% CI, 1.03–3.77 and HR, 2.74; 95% CI, 1.51–5.00, respectively) but not AD. Hippocampal volume at the bottom quintile predicted AD in the offspring and original cohorts (HR, 4.41; 95% CI, 2.00–9.72 and HR, 2.37; 95% CI, 1.12–5.00, respectively). A stepwise increase in stroke risk was apparent with increasing numbers of these cognitive and imaging markers.

Conclusions—Specific patterns of cognitive and brain structural measures observed even in early aging predict stroke risk and may serve as biomarkers for risk prediction.